2nd Quarter - Report
CURA STRATEGIES for PKD FOUNDATION
Firm
Client
Income
$15,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Health Issues HCR
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Defense DEF
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.